Chemical Compound

1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-ss-oxo-, (3S,4S)-; (3S,4S)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-ss-oxo-1-piperidinepropanenitrile; (3S,4S)-Tofacitinib; ent-Tofacitinib

CAS Registry Number 1092578-47-6
返回搜索 申请报价
1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-ss-oxo-, (3S,4S)-; (3S,4S)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-ss-oxo-1-piperidinepropanenitrile; (3S,4S)-Tofacitinib; ent-Tofacitinib 结构式
Primary record

1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-ss-oxo-, (3S,4S)-; (3S,4S)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-ss-oxo-1-piperidinepropanenitrile; (3S,4S)-Tofacitinib; ent-Tofacitinib

库存
5,148 克
纯度
98.9 %
CAS
1092578-47-6

化合物标识与属性

CAS
1092578-47-6
PubChem CID
20111936
SMILES
C[C@H]1CCN(C[C@H]1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N
Canonical SMILES
C[C@H]1CCN(C(=O)CC#N)C[C@H]1N(C)c1ncnc2[nH]ccc12

名称与同义词

  • (3S,4S)-Tofacitinib
  • 1092578-47-6
  • Tasocitinib
  • Tofacitinib
  • (-)-Tofacitinib
  • racemic-Tasocitinib
  • Tofacitinib Impurity C
  • Tofacitinib Impurity Q
  • C3EP7ZZ9UQ
  • Tofacitinib, (3S,4S)-
  • UNII-C3EP7ZZ9UQ
  • CHEMBL459769
  • C16H20N6O
  • TOFACITINIB IMPURITY 3
  • MFCD11035920
  • orb1708149
  • SCHEMBL23058868
  • SCHEMBL30341861
  • Tofacitinib Impurity 62 Citrate
  • 3-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
  • AMY6188
  • AOB5921
  • DTXSID10602594
  • GLXC-06842
  • STB57847
  • 3197AH
  • BDBM50273930
  • HY-40354C
  • ZINC13974880
  • AKOS016015817
  • ACN-027536
  • CS-1108
  • RL06158
  • NCGC00348153-01
  • AS-74811
  • SC-28461
  • Tofacitinib Impurity C (Racimic Mixture)
  • B1031
  • 3-[(3S,4S)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile
  • D88145
  • W-5456
  • A948042
  • A1-24394
  • 3-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyr
  • B2694-463515
  • N0001-010335
  • 3-[(3S,4S)-4-METHYL-3-[METHYL(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]-1-PIPERIDYL]-3-OXO-PROPANENITRILE
  • 3-((3S,4S)-4-Methyl-3-(methyl(7H-pyrrolo(2,3-d)pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
  • 3-[(3S,4S)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile
  • (3S,4S)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-|_-oxo-1-piperidinepropanenitrile
  • (3S,4S)-Tofacitinib; 3-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile; (3S,4S)-4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-beta-oxo-1-piperidinepropanenitrile; 1-Piperidin
  • 1-PIPERIDINEPROPANENITRILE, 4-METHYL-3-(METHYL-7H-PYRROLO(2,3-D)PYRIMIDIN-4-YLAMINO)-.BETA.-OXO-, (3S,4S)-
  • 1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo(2,3-d)pyrimidin-4-ylamino)-beta-oxo-, (3S,4S)-
  • 1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-ss-oxo-, (3S,4S)-; (3S,4S)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-ss-oxo-1-piperidinepropanenitrile; (3S,4S)-Tofacitinib; ent-Tofacitinib
  • 1259404-17-5
  • 3-{(3S,4S)-4-Methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile
  • 477600-75-2